Lista de obras - Kwong-Kwok Wong - Dominio Público Uruguay

A long-term surviving patient with recurrent low-grade serous ovarian carcinoma treated with the MEK1/2 inhibitor, selumetinib

artículo científico publicado en 2016

A novel method for producing partial restriction digestion of DNA fragments by PCR with 5-methyl-CTP

artículo científico publicado en 1997

Allelic imbalance analysis by high-density single-nucleotide polymorphic allele (SNP) array with whole genome amplified DNA.

artículo científico publicado en 2004

Amplification of MGC2177, PLAG1, PSMC6P, and LYN in a malignant mixed tumor of salivary gland detected by cDNA microarray with tyramide signal amplification

artículo científico publicado en 2004

BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas

artículo científico publicado en 2010

Biomarker discovery in epithelial ovarian cancer by genomic approaches.

artículo científico publicado en 2007

Biomarker discovery in ovarian cancer.

artículo científico publicado en 2008

Breast cancer cells expressing stem cell markers CD44+ CD24 lo are eliminated by Numb-1 peptide-activated T cells.

artículo científico publicado en 2008

Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potential

artículo científico publicado en 2014

Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance

artículo científico publicado en 2017

Candidate tumor-suppressor gene DLEC1 is frequently downregulated by promoter hypermethylation and histone hypoacetylation in human epithelial ovarian cancer

artículo científico publicado en 2006

Characterization of miR-200 family members as blood biomarkers for human and laying hen ovarian cancer

scientific article published on 18 November 2020

Clinical applications of microarray technology: creatine kinase B is an up-regulated gene in epithelial ovarian cancer and shows promise as a serum marker

artículo científico publicado en 2005

Clusterin interacts with Paclitaxel and confer Paclitaxel resistance in ovarian cancer

artículo científico publicado en 2008

Created Gli-1 duplex short-RNA (i-Gli-RNA) eliminates CD44 Hi progenitors of taxol-resistant ovarian cancer cells

artículo científico publicado en 2010

DNA fingerprinting by arbitrarily primed PCR (RAPDs)

DNA methylation promotes paired box 2 expression via myeloid zinc finger 1 in endometrial cancer

artículo científico publicado en 2016

Deep learning can predict prognosis and endocrine therapy response in breast cancer patients from H&amp;E staining based on estrogen receptor signaling activity

Deep learning-enabled breast cancer endocrine response determination from H&E staining based on ESR1 signaling activity

artículo científico publicado en 2023

Differences in gynecologic tumor development in Amhr2-Cre mice with KRASG12D or KRASG12V mutations

scientific article published on 26 November 2020

Differential expression of survivin splice isoforms in medulloblastomas.

artículo científico publicado en 2007

Direct orthotopic transplantation of fresh surgical specimen preserves CD133+ tumor cells in clinically relevant mouse models of medulloblastoma and glioma.

artículo científico publicado en 2008

ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells.

artículo científico publicado en 2017

Etiology and pathogenesis of epithelial ovarian cancer

scientific article published on January 2007

Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1.

artículo científico publicado en 2016

Expression analysis of juvenile pilocytic astrocytomas by oligonucleotide microarray reveals two potential subgroups

article by Kwong-Kwok Wong et al published 1 January 2005 in Cancer Research

Expression of oligodendroglial differentiation markers in pilocytic astrocytomas identifies two clinical subsets and shows a significant correlation with proliferation index and progression free survival

artículo científico publicado en 2007

Expression profiles of osteosarcoma that can predict response to chemotherapy.

artículo científico publicado en 2005

Gene expression profiling reveals signatures characterizing histologic subtypes of hepatoblastoma and global deregulation in cell growth and survival pathways

artículo científico publicado en 2009

Genome-wide allelic imbalance analysis of pediatric gliomas by single nucleotide polymorphic allele array.

artículo científico publicado en 2006

Global analysis of the Deinococcus radiodurans proteome by using accurate mass tags

artículo científico publicado en 2002

Hyposplenism after allogeneic bone marrow transplantation

artículo científico publicado en 2002

ISG15 Promotes ERK1 ISGylation, CD8+ T Cell Activation and Suppresses Ovarian Cancer Progression

article published in 2018

Identification of DNA copy number changes in microdissected serous ovarian cancer tissue using a cDNA microarray platform

artículo científico publicado en 2004

Identification of FGFR4 as a potential therapeutic target for advanced-stage, high-grade serous ovarian cancer

artículo científico publicado en 2013

Identification of overexpression and amplification of ABCF2 in clear cell ovarian adenocarcinomas by cDNA microarray analyses.

artículo científico publicado en 2005

Impact of Age and Primary Disease Site on Outcome in Women With Low-Grade Serous Carcinoma of the Ovary or Peritoneum: Results of a Large Single-Institution Registry of a Rare Tumor.

artículo científico publicado en 2015

Impact of estrogen receptor expression on prognosis of ovarian cancer according to antibody clone used for immunohistochemistry: a meta-analysis

artículo científico publicado en 2022

Impact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinoma.

artículo científico publicado en 2017

Impact of mutational status on survival in low-grade serous carcinoma of the ovary or peritoneum.

artículo científico publicado en 2015

Inflammatory cytokine tumor necrosis factor alpha confers precancerous phenotype in an organoid model of normal human ovarian surface epithelial cells

artículo científico publicado en 2009

Insulin-like growth factor: current concepts and new developments in cancer therapy

artículo científico publicado en 2012

Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors

artículo científico publicado en 2022

Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas

artículo científico publicado en 2014

KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27kip1

artículo científico publicado en 2015

KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma

artículo científico publicado en 2013

Loss of ARID1A expression leads to sensitivity to ROS-inducing agent elesclomol in gynecologic cancer cells

artículo científico publicado en 2016

Low-grade serous carcinoma: new concepts and emerging therapies.

artículo científico

Low-grade serous ovarian cancer: State of the science

scientific article published on 20 January 2020

Low-grade serous ovarian cancer: expert consensus report on the state of the science

scientific article published on 17 August 2023

Mass spectrometic detection for capillary isoelectric focusing separations of complex protein mixtures

Mass spectrometric detection for capillary isoelectric focusing separations of complex protein mixtures

artículo científico publicado en 2000

Mitogen stimulation activates different signaling pathways in early- and late-divided T cells as revealed by cDNA microarray analysis.

artículo científico publicado en 2006

Molecular and functional characteristics of ovarian surface epithelial cells transformed by KrasG12D and loss of Pten in a mouse model in vivo.

artículo científico publicado en 2011

Molecular cloning of differentially expressed genes in human epithelial ovarian cancer.

artículo científico publicado en 1994

Mutant p53 Promotes Epithelial Ovarian Cancer by Regulating Tumor Differentiation, Metastasis, and Responsiveness to Steroid Hormones.

artículo científico publicado en 2016

Nutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian Carcinomas

artículo científico publicado en 2015

Oral-specific chemical carcinogenesis in mice: an exciting model for cancer prevention and therapy.

artículo científico publicado en 2009

Organic data memory using the DNA approach

article

PAX2 Expression in Ovarian Cancer

artículo científico publicado en 2013

PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas

artículo científico publicado en 2009

PCR with 5-methyl-dCTP replacing dCTP.

artículo científico publicado en 1991

PRKRA/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer

artículo científico publicado en 2018

Pathogenesis and Clinical Management of Uterine Serous Carcinoma

artículo científico publicado en 2020

Poor survival with wild-type TP53 ovarian cancer?

artículo científico publicado en 2013

RAS promotes tumorigenesis through genomic instability induced by imbalanced expression of Aurora-A and BRCA2 in midbody during cytokinesis.

artículo científico publicado en 2013

Recent developments in anti-cancer agents targeting the Ras/Raf/ MEK/ERK pathway.

artículo científico publicado en 2009

Significantly greater expression of ER, PR, and ECAD in advanced-stage low-grade ovarian serous carcinoma as revealed by immunohistochemical analysis

artículo científico publicado en 2007

Spatial Transcriptomics Depict Ligand–Receptor Cross-talk Heterogeneity at the Tumor-Stroma Interface in Long-Term Ovarian Cancer Survivors

artículo científico publicado en 2023

Specific TP53 Mutants Overrepresented in Ovarian Cancer Impact CNV, TP53 Activity, Responses to Nutlin-3a, and Cell Survival.

artículo científico publicado en 2015

TGF-β modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment.

artículo científico publicado en 2013

Targeting SRC in mucinous ovarian carcinoma.

artículo científico publicado en 2011

Targeting aurora kinase with MK-0457 inhibits ovarian cancer growth.

scientific article published on September 2008

The Role of GDF15 in Regulating the Canonical Pathways of the Tumor Microenvironment in Wild-Type p53 Ovarian Tumor and Its Response to Chemotherapy

artículo científico publicado en 2020

The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer

artículo científico publicado en 2011

The continuum of serous tumors of low malignant potential and low-grade serous carcinomas of the ovary

scientific article published on January 2007

The efficacy of a novel vaccine approach using tumor cells that ectopically express a codon-optimized murine GM-CSF in a murine tumor model.

artículo científico publicado en 2015

The genomic landscape of low-grade serous ovarian/peritoneal carcinoma and its impact on clinical outcomes

artículo científico publicado en 2022

The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma

artículo científico publicado en 2011

The molecular pathology of ovarian serous borderline tumors.

artículo científico publicado en 2016

The role of neoadjuvant chemotherapy in the management of low-grade serous carcinoma of the ovary and peritoneum: Further evidence of relative chemoresistance

scientific article published on 22 July 2020

Tumor repressor protein 53 and steroid hormones provide a new paradigm for ovarian cancer metastases

scientific article published on January 2013

USP15-dependent lysosomal pathway controls p53-R175H turnover in ovarian cancer cells

artículo científico publicado en 2018

Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Promotes Uterine Serous Cancer Cell Proliferation and Cell Cycle Progression

scientific article published on 02 January 2020

Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor 1 as a prognostic marker for advanced-stage serous ovarian adenocarcinomas

artículo científico publicado en 2007

Whole-genome allelotyping identified distinct loss-of-heterozygosity patterns in mucinous ovarian and appendiceal carcinomas

scientific article published on 01 November 2005

Wild-type tumor repressor protein 53 (Trp53) promotes ovarian cancer cell survival

artículo científico publicado en 2012

Lista de obras de Kwong-Kwok Wong

A long-term surviving patient with recurrent low-grade serous ovarian carcinoma treated with the MEK1/2 inhibitor, selumetinib

A novel method for producing partial restriction digestion of DNA fragments by PCR with 5-methyl-CTP

Allelic imbalance analysis by high-density single-nucleotide polymorphic allele (SNP) array with whole genome amplified DNA.

Amplification of MGC2177, PLAG1, PSMC6P, and LYN in a malignant mixed tumor of salivary gland detected by cDNA microarray with tyramide signal amplification

BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas

Biomarker discovery in epithelial ovarian cancer by genomic approaches.

Biomarker discovery in ovarian cancer.

Breast cancer cells expressing stem cell markers CD44+ CD24 lo are eliminated by Numb-1 peptide-activated T cells.

Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potential

Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance

Candidate tumor-suppressor gene DLEC1 is frequently downregulated by promoter hypermethylation and histone hypoacetylation in human epithelial ovarian cancer

Characterization of miR-200 family members as blood biomarkers for human and laying hen ovarian cancer

Clinical applications of microarray technology: creatine kinase B is an up-regulated gene in epithelial ovarian cancer and shows promise as a serum marker

Clusterin interacts with Paclitaxel and confer Paclitaxel resistance in ovarian cancer

Created Gli-1 duplex short-RNA (i-Gli-RNA) eliminates CD44 Hi progenitors of taxol-resistant ovarian cancer cells

DNA fingerprinting by arbitrarily primed PCR (RAPDs)

DNA methylation promotes paired box 2 expression via myeloid zinc finger 1 in endometrial cancer

Deep learning can predict prognosis and endocrine therapy response in breast cancer patients from H&amp;amp;E staining based on estrogen receptor signaling activity

Deep learning-enabled breast cancer endocrine response determination from H&amp;E staining based on ESR1 signaling activity

Differences in gynecologic tumor development in Amhr2-Cre mice with KRASG12D or KRASG12V mutations

Differential expression of survivin splice isoforms in medulloblastomas.

Direct orthotopic transplantation of fresh surgical specimen preserves CD133+ tumor cells in clinically relevant mouse models of medulloblastoma and glioma.

ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells.

Etiology and pathogenesis of epithelial ovarian cancer

Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1.

Expression analysis of juvenile pilocytic astrocytomas by oligonucleotide microarray reveals two potential subgroups

Expression of oligodendroglial differentiation markers in pilocytic astrocytomas identifies two clinical subsets and shows a significant correlation with proliferation index and progression free survival

Expression profiles of osteosarcoma that can predict response to chemotherapy.

Gene expression profiling reveals signatures characterizing histologic subtypes of hepatoblastoma and global deregulation in cell growth and survival pathways

Genome-wide allelic imbalance analysis of pediatric gliomas by single nucleotide polymorphic allele array.

Global analysis of the Deinococcus radiodurans proteome by using accurate mass tags

Hyposplenism after allogeneic bone marrow transplantation

ISG15 Promotes ERK1 ISGylation, CD8+ T Cell Activation and Suppresses Ovarian Cancer Progression

Identification of DNA copy number changes in microdissected serous ovarian cancer tissue using a cDNA microarray platform

Identification of FGFR4 as a potential therapeutic target for advanced-stage, high-grade serous ovarian cancer

Identification of overexpression and amplification of ABCF2 in clear cell ovarian adenocarcinomas by cDNA microarray analyses.

Impact of Age and Primary Disease Site on Outcome in Women With Low-Grade Serous Carcinoma of the Ovary or Peritoneum: Results of a Large Single-Institution Registry of a Rare Tumor.

Impact of estrogen receptor expression on prognosis of ovarian cancer according to antibody clone used for immunohistochemistry: a meta-analysis

Impact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinoma.

Impact of mutational status on survival in low-grade serous carcinoma of the ovary or peritoneum.

Inflammatory cytokine tumor necrosis factor alpha confers precancerous phenotype in an organoid model of normal human ovarian surface epithelial cells

Insulin-like growth factor: current concepts and new developments in cancer therapy

Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors

Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas

KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27kip1

KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma

Loss of ARID1A expression leads to sensitivity to ROS-inducing agent elesclomol in gynecologic cancer cells

Low-grade serous carcinoma: new concepts and emerging therapies.

Low-grade serous ovarian cancer: State of the science

Low-grade serous ovarian cancer: expert consensus report on the state of the science

Mass spectrometic detection for capillary isoelectric focusing separations of complex protein mixtures

Mass spectrometric detection for capillary isoelectric focusing separations of complex protein mixtures

Mitogen stimulation activates different signaling pathways in early- and late-divided T cells as revealed by cDNA microarray analysis.

Molecular and functional characteristics of ovarian surface epithelial cells transformed by KrasG12D and loss of Pten in a mouse model in vivo.

Molecular cloning of differentially expressed genes in human epithelial ovarian cancer.

Mutant p53 Promotes Epithelial Ovarian Cancer by Regulating Tumor Differentiation, Metastasis, and Responsiveness to Steroid Hormones.

Nutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian Carcinomas

Oral-specific chemical carcinogenesis in mice: an exciting model for cancer prevention and therapy.

Organic data memory using the DNA approach

PAX2 Expression in Ovarian Cancer

PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas

PCR with 5-methyl-dCTP replacing dCTP.

PRKRA/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer

Pathogenesis and Clinical Management of Uterine Serous Carcinoma

Poor survival with wild-type TP53 ovarian cancer?

RAS promotes tumorigenesis through genomic instability induced by imbalanced expression of Aurora-A and BRCA2 in midbody during cytokinesis.

Recent developments in anti-cancer agents targeting the Ras/Raf/ MEK/ERK pathway.

Significantly greater expression of ER, PR, and ECAD in advanced-stage low-grade ovarian serous carcinoma as revealed by immunohistochemical analysis

Spatial Transcriptomics Depict Ligand–Receptor Cross-talk Heterogeneity at the Tumor-Stroma Interface in Long-Term Ovarian Cancer Survivors

Specific TP53 Mutants Overrepresented in Ovarian Cancer Impact CNV, TP53 Activity, Responses to Nutlin-3a, and Cell Survival.

TGF-β modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment.

Targeting SRC in mucinous ovarian carcinoma.

Targeting aurora kinase with MK-0457 inhibits ovarian cancer growth.

The Role of GDF15 in Regulating the Canonical Pathways of the Tumor Microenvironment in Wild-Type p53 Ovarian Tumor and Its Response to Chemotherapy

The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer

The continuum of serous tumors of low malignant potential and low-grade serous carcinomas of the ovary

The efficacy of a novel vaccine approach using tumor cells that ectopically express a codon-optimized murine GM-CSF in a murine tumor model.

The genomic landscape of low-grade serous ovarian/peritoneal carcinoma and its impact on clinical outcomes

The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma

Deep learning can predict prognosis and endocrine therapy response in breast cancer patients from H&E staining based on estrogen receptor signaling activity

Deep learning-enabled breast cancer endocrine response determination from H&E staining based on ESR1 signaling activity